Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;13(3):582-597.
doi: 10.1007/s13668-024-00543-x. Epub 2024 May 24.

Effect of Barley and Oat Consumption on Immune System, Inflammation and Gut Microbiota: A Systematic Review of Randomized Controlled Trials

María-Engracia Cortijo-Alfonso  1 , María-Paz Romero  1 , Alba Macià  1 , Silvia Yuste  1 , Marian Moralejo  1 , Laura Rubió-Piqué  2 , Carme Piñol-Felis  3   4
Affiliations

Effect of Barley and Oat Consumption on Immune System, Inflammation and Gut Microbiota: A Systematic Review of Randomized Controlled Trials

María-Engracia Cortijo-Alfonso et al. Curr Nutr Rep. 2024 Sep.

Abstract

Purpose of review: The aim of this systematic review was to investigate the effects of whole grain Avena sativa and Hordeum vulgare L., or their isolated fractions, on immune and inflammatory functions, as well as their influence on gut microbiota. A structured literature search was undertaken in line with PRISMA guidelines. Randomized controlled trials (RCTs) that investigated the effects of oats or barley consumption in adults and reported ≥ 1 of the following: C-reactive protein (CRP), tumor necrosis factor (TNF-α), interleukin-6 (IL-6), IL-2, IL-8, IL-18, lipopolysacharide binding protein (LBP) or gut microbiota-related outcomes, were included.

Recent findings: A total of 16 RCTs were included, among which 6 studies recruited metabolically at-risk population, including individuals with overweight and obesity, metabolic syndrome or hypercholesterolemia. Additionally, 3 trials involved young healthy population, 5 trials targeted older individuals (aged over 50 years), and 2 studies encompassed populations with other disease states. A total of 1091 individuals were included in the evaluation of short-term (up to 14 days) and long-term (beyond 14 days, up to 90 days) supplementation with oats or barley-based products. 9 studies measured inflammatory biomarkers and 5 of them reported significant reductions, specifically in long-term studies. Notably, no evidence of anti-inflammatory benefits was found in healthy individuals, whereas studies involving metabolically at-risk populations showed promising reductions in inflammation. 13 studies measured the impact on gut microbiota, and collectively suggest that oats and barley food products can influence the composition of gut microbiota, associated in some cases with metabolic improvements. Oats and barley consumption may confer anti-inflammatory effects in metabolically at-risk populations and influence gut microbiota outcomes. However, no anti-inflammatory benefits were observed in healthy individuals. Results from this systematic review suggests caution in interpreting findings due to limited trials and variations in interventions and health conditions.

Keywords: Barley; Gut microbiota; Immune function; Inflammation; Oats; Systematic review; β-glucans.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flow diagram for study selection
Fig. 2
Fig. 2
Risk of bias assessment using the revised Cochrane risk-of-bias (RoB 2)
See this image and copyright information in PMC

References

    1. Hu H, et al. Consumption of whole grains and refined grains and associated risk of cardiovascular disease events and all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr. 2023;117(1):149–59. 10.1016/j.ajcnut.2022.10.010. 10.1016/j.ajcnut.2022.10.010 - DOI - PubMed
    1. Wood PJ. Cereal β-glucans in diet and health. J Cereal Sci. 2017;46(3):230–8. 10.1016/j.jcs.2007.06.012. 10.1016/j.jcs.2007.06.012 - DOI
    1. Scientific Opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and ‘digestive function’ (ID 850) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. https://efsa.onlinelibrary.wiley.com/doi/abs/10.2903/j.efsa.2011.2207.
    1. FDA Food labeling: Health claims, soluble dietary fiber from certain foods and coronary heart disease. https://www.federalregister.gov/documents/2008/02/25/E8-3418/food-labeli....
    1. Jayachandran M, Chen J, Chung SSM, Xu B. A critical review on the impacts of β-glucans on gut microbiota and human health. J Nutr Biochem. 2018;61:101–10. 10.1016/J.JNUTBIO.2018.06.010. 10.1016/J.JNUTBIO.2018.06.010 - DOI - PubMed

Publication types

LinkOut - more resources